HLA-DPB1 and cervical carcinoma: The results showed that HLA-DPB1∗03:01 was significantly associated with an increased risk of cervical cancer (OR=1.354, 95%CI: 1.144-1.604, Pz=0.001) (Figure 2), while HLA-DPB1∗04:02 was significantly associated with a decreased risk of cervical cancer risk (OR=0.750, 95%CI: 0.642-0.877, Pz=0.001) (Figure 3), and HLA-DP rs9277535 G allele was significantly associated with a decreased risk of cervical cancer risk in Asia (OR=0.800, 95%CI: 0.740-0.865, Pz=0.001) (Figure 4).